CordenPharma buys AmbioPharm to boost its global peptide API capacity
Under the agreement, the Switzerland-headquartered CDMO will acquire AmbioPharm’s two manufacturing facilities in North Augusta, South Carolina and Shanghai, China.
Read the full article on the original site.
Read Full Article